The combination of MRI and PET is widely recognized as a highly efficient hybrid imaging modality in neurology. The capability of magnetic resonance imaging (MRI) to depict the brain's structure, along with its ability to assess physiological and metabolic aspects such as perfusion, edema, vascular supply, and functional activation, enhances its appeal when used in conjunction with PET Systems. Consequently, the combined data from the MRI and PET hybrid imaging systems play a crucial role in improving the diagnosis of neurological conditions.
PET-MRI systems for the brain have created new possibilities for multiparametric neuroimaging by simultaneously observing the brain's physiological and biochemical processes. Consequently, there is a growing trend of installing these devices in various medical settings. Furthermore, companies are conducting research to assess the efficacy of MRI-PET scanners in both animal and human subjects.
The use of brain PET-MRI systems in preclinical imaging is on the rise, creating opportunities for new market entrants. There has been a significant global push to enhance MRI resolution for studying the human brain, resulting in the development of an ultra-high-resolution 7 Tesla scanner. This scanner can capture up to 10 times more detail than current 7T scanners and over 50 times more detail than current 3T scanners, which are widely used in most hospitals. The enhanced clarity allows scientists to observe fMRI features as small as 0.4 millimeters, compared with the usual 2 or 3 millimeters in the current standard 3T fMRI.
Brain PET-MRI Systems Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global brain PET-MRI systems market report based on phase, product, end use, and region:Phase Outlook (Revenue, USD Million, 2021 - 2033)
- Clinical
- Pre-clinical
Product Outlook (Revenue, USD Million, 2021 - 2033)
- Traditional PET-MRI systems
- Helium-free PET-MRI systems
End Use Outlook (Revenue, USD Million, 2021 - 2033)
▪ Hospitals▪ Diagnostic imaging centers
▪ Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
▪ North America- U.S.
- Canada
- Mexico
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- China
- Japan
- India
- Thailand
- South Korea
- Australia
- Brazil
- Argentina
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- GE Healthcare.
- Bruker
- Mediso Ltd.
- MR Solutions
- Cubresa Inc.
- Aspect Imaging Ltd.
- Shanghai United Imaging Healthcare Co., LTD
- MILabs B.V.

